[1]
S. Hanifah, P. Ball, and R. A. Kennedy, “Management of Y-Site Incompatibility of Intravenous Medication: A Scoping Review”, Indonesian J Pharm, vol. 33, no. 3, pp. 353-365, Sep. 2022.